Wrong About Inflammation & Heart Disease (new study)

This site does not allow itself to be embedded. You can still read it on the original site — the toolbar below keeps your place in the directory.

On the 31st of July, a drug company found out it had just lost about thirty billion dollars in a single day. Novo Nordisk's stock-market value fell from $229.2 billion to $198.5 billion — a drop of $30.7 billion, on a share price fall of roughly 9 to 10 percent [1]. But their drug worked perfectly to lower inflammation, and inflammation is a key driver of heart disease. Doesn't make sense, right?…

Read on drstanfield.com ↗